Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia
Sponsor: University of Maryland, Baltimore
Summary
Aim: Demonstrate the equivalent efficacy and superior safety of Ceftriaxone 1 gram daily compared with Ceftriaxone 2 grams daily among hospitalized patients with community-acquired pneumonia who are not admitted to the intensive care unit.\<p\> Hypothesis: Among hospitalized patients outside of the intensive care unit with community-acquired pneumonia who are prescribed Ceftriaxone, a dosage of 1 gram daily will be associated with an equivalent rate of clinical cure and fewer adverse events than a dosage of 2 grams daily.
Official title: Pragmatic Randomized Trial Evaluating Dosage of Ceftriaxone for Community-Acquired Pneumonia Outside the Intensive Care Unit
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
900
Start Date
2026-09-01
Completion Date
2028-02-28
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
Ceftriaxone 1 gram daily
Intravenous Ceftriaxone will be dosed 1 gram daily per institutional guidance for treatment of non-critical community-acquired pneumonia.
Ceftriaxone 2 grams daily
Intravenous Ceftriaxone will be dosed at 2 grams daily per institutional guidance for treatment of community-acquired pneumonia.
Locations (4)
University of Maryland Medical Center - Midtown Campus
Baltimore, Maryland, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
UM Baltimore Washington Medical Center
Glen Burnie, Maryland, United States
University of Maryland St. Joseph Medical Center
Towson, Maryland, United States